- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Injectable insulin
Total 3681 results
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Mexico, Israel, Taiwan, Malaysia, Hungary, Turkey, Morocco, Germany, South Africa, Portugal, Lebanon, Italy, Brazil, Croatia, Egypt, Spain, Russian Federation, Greece, Argentina, Korea, Republic of, Poland, Serbia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Indonesia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Russian Federation, Denmark, Sweden, Macedonia, The Former Yugoslav Republic of, Norway, Croatia, France, Belgium, Slovakia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Mexico, Puerto Rico, Canada, Denmark, France, Austria, Taiwan, Czechia, Brazil, China, Argentina
-
HaEmek Medical Center, IsraelCompletedDiabetes Mellitus Type 2
-
HealthPartners InstituteSanofi; International Diabetes Center at Park NicolletCompletedHyperglycemiaUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, United Kingdom, Denmark, Netherlands, Norway, South Africa, Finland, France, Spain, Former Serbia and Montenegro, Sweden
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, France, Argentina, Macedonia, The Former Yugoslav Republic of, Slovenia, Canada, Brazil
-
SanofiCompletedDiabetes Mellitus, Type 1France
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Sweden
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Russian Federation, United Kingdom, Canada, France, Netherlands, Belgium, Germany, Slovenia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesRomania
-
Novo Nordisk A/SCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, United States, Japan, Netherlands, Russian Federation, Bulgaria, United Kingdom, North Macedonia, South Africa, Italy, Finland
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Denmark, Spain, Norway, Italy, France, Netherlands
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Germany, Austria, Denmark, Norway, Sweden, Switzerland, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Germany, Turkey, Greece
-
University of MinnesotaCompletedCystic FibrosisUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2Germany
-
SanofiCompletedDiabetes Mellitus, Type 1France, Australia, Spain, Sweden, United States, Austria, Hungary, Israel, Italy, United Kingdom, Korea, Republic of, Netherlands
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Acute Myocardial InfarctionCanada, Croatia, Czech Republic, Germany, Hungary, India, Israel, Lebanon, Poland, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Turkey, United Kingdom
-
Beijing HospitalNot yet recruitingType 2 Diabetes MellitusChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
SanofiCompletedDiabetes Mellitus, Type 2France, Spain, Italy, Belgium, Germany, Poland, Portugal, Czech Republic, Slovakia, Australia, Netherlands, Sweden, United Kingdom, Switzerland, Romania
-
Medical University of WarsawCompleted
-
University of PalermoCompleted
-
University of AarhusNovo Nordisk A/SCompletedDiabetes Mellitus, Type 1Denmark
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1United States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
SanofiCompletedDiabetes Mellitus, Type 2Australia, United Kingdom
-
University of AarhusCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Mexico, Russian Federation, Netherlands, Belgium, Italy, India, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, France, United Kingdom, Russian Federation, Germany, South Africa
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, United Kingdom, Belgium, Norway, Germany, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Spain, Russian Federation, Turkey, Austria, India, Korea, Republic of
-
Imperial College LondonTerminated